Bright Minds Biosciences Announces Successful Completion of 28-Day Toxicology Studies and…
VANCOUVER, British Columbia, March 14, 2022 (GLOBE NEWSWIRE) -- Bright minds Biosciences ("Bright Minds", "BMB" or the "Company") (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on the development of novel drugs for the…